Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 17, 2021
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
Fri, May 14, 2021
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
Sean Lee Maintained (CASI) at Strong Buy with Increased Target to $40 on, May 14th, 2021
Sean Lee of HC Wainwright & Co., Maintained "CASI Pharmaceuticals, Inc." (CASI) at Strong Buy with Increased Target from $35 to $40 on, May 14th, 2021.
Sean has made no other calls on CASI in the last 4 months.
There is 1 other peer that has a rating on CASI. Out of the 1 peers that are also analyzing CASI, 0 agree with Sean's Rating of Hold.
This is the rating of the analyst that currently disagrees with Sean
- Difei Yang of "Mizuho" Initiated at Strong Buy and Held Target at $38 on, Monday, April 26th, 2021
